U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07730619) titled 'To Explore the Influencing Factors and Solutions for Patients With Plaque Psoriasis Undergoing Relapse' on July 16.
Brief Summary: In recent years, an increasing number of patients who have experienced poor efficacy or adverse drug reactions using traditional treatment regimens have received biologic therapy and achieved satisfactory treatment results. However, we also found that some patients have poor reactions to biological agents. Biological agents are often the final treatment choice for most patients, and patients often have high expectations for this treatment plan. Therefore, exploring the factors that affect the efficacy of...